Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study.

Wei WangRuixia LiHui LiMurong WangJuncheng WangXiao-Hui Wang Qunfang Zhou

Published in: ImmunoTargets and therapy (2024)

The HAIC+Len+ICI group had a longer PFS and OS compared with the HAIC+Len group, demonstrating an acceptable safety profile. This triple combination strategy may be an alternative treatment for infiltrative HCC management.

Keyphrases

low dose
squamous cell carcinoma
combination therapy
double blind
replacement therapy
smoking cessation